- Global economic uncertainties
- Geopolitical risks affecting supply chains
- Regulatory compliance costs
SMS Pharmaceuticals Limited
Greenhouse gas emissions & sustainability report data
In its 2023-24 reporting, SMS Pharmaceuticals Limited disclosed greenhouse gas emissions of 70.0K Metric tonnes of CO2 equivalent (Scope 1 & 2). By scope: Scope 1: 37.4K Metric tonnes of CO2 equivalent; Scope 2: 42.4K Metric tonnes of CO2 equivalent; Scope 3: 200.61 Metric tonnes of CO2 equivalent. Figures are as stated in the company's own report and may use different boundaries, units or methods (for example market-based vs location-based Scope 2), so compare with care.
📊 Emissions by Scope (2023-24)
| Scope | What it covers | Reported value |
|---|---|---|
| Scope 1 | Direct emissions from sources the company owns or controls (fuel combustion, company vehicles, process and fugitive emissions). | 37.4K Metric tonnes of CO2 equivalent |
| Scope 2 | Indirect emissions from purchased electricity, steam, heat and cooling. | 42.4K Metric tonnes of CO2 equivalent |
| Scope 3 | Other indirect emissions across the value chain (purchased goods, business travel, use of sold products, etc.). | 200.61 Metric tonnes of CO2 equivalent |
New to scopes? Read Scope 1, 2 and 3 emissions explained and market-based vs location-based Scope 2.
📈 Emissions by Report Period
| Report period | Headline emissions figure reported |
|---|---|
| 2023-24 | 70.0K Metric tonnes of CO2 equivalent (Scope 1 & 2) |
| 2022-03 to 2023-03 | 61.3K tCO2e/year (Scope 1 & 2) |
Each row is the headline figure extracted from a different report; scope coverage and methodology can change between years.
✅ Reported Environmental Achievements
- Received the Indo-US GCNC award for implementing green chemistry practices
- Developed a commercial process to produce Neopentyl glycol from waste generated during Ibuprofen synthesis
- Operates as a Zero Liquid Discharge (ZLD) unit at Hyderabad